Searched over 200M research papers
10 papers analyzed
These studies suggest that individuals with type 1 diabetes generally have a reduced life expectancy compared to the general population, but improvements in medical care and management have led to increased life expectancy over time.
20 papers analyzed
Research indicates significant improvements in the life expectancy of individuals with type 1 diabetes over the past few decades. A study focusing on the Pittsburgh Epidemiology of Diabetes Complications (EDC) cohort revealed that individuals diagnosed between 1965 and 1980 had a life expectancy at birth approximately 15 years greater than those diagnosed between 1950 and 1964, with life expectancies of 68.8 years and 53.4 years, respectively. This improvement underscores the advancements in diabetes management and treatment over time.
Similarly, data from the Swedish National Diabetes Register showed an increase in life expectancy for men with type 1 diabetes from 47.7 years in 2002-2006 to 49.7 years in 2007-2011. However, the increase for women was minimal, from 51.7 to 51.9 years during the same periods. These findings highlight the ongoing progress in diabetes care, particularly in reducing cardiovascular mortality, which has been a significant driver of these gains.
A national Australian registry-based cohort study estimated the life expectancy of individuals with type 1 diabetes at 68.6 years, which is 12.2 years less than the general population. This study also identified that deaths before age 60 accounted for a substantial portion of the years of life lost, with endocrine and metabolic diseases being major contributors to mortality in younger age groups, and circulatory diseases in older age groups.
In Scotland, a study found that men with type 1 diabetes had an estimated life expectancy of 46.2 years from age 20, compared to 57.3 years for men without diabetes, resulting in an 11.1-year reduction. For women, the life expectancy was 48.1 years compared to 61.0 years for those without diabetes, indicating a 12.9-year reduction. These reductions were primarily attributed to ischemic heart disease and diabetic complications such as ketoacidosis.
A study developing a life expectancy table for individuals with type 1 diabetes identified significant variations in life expectancy based on modifiable risk factors such as smoking status, BMI, eGFR, and HbA1c levels. For instance, 20-year-old men with optimal risk factor levels had a life expectancy of 50.6 years, compared to 29.3 years for those with the worst risk factor levels. Similarly, for women, the life expectancy ranged from 35.0 to 53.9 years depending on their risk factor profiles. This highlights the critical role of managing these risk factors in improving life expectancy for individuals with type 1 diabetes.
People with type 1 diabetes generally have a more significant reduction in life expectancy compared to those with type 2 diabetes. For instance, a study in the Netherlands found that 45-year-olds with type 1 diabetes live on average 13 years shorter than those without diabetes, whereas those with type 2 diabetes live about 4 years shorter. This difference is partly due to the unavoidable nature of type 1 diabetes and the higher prevalence of other chronic diseases in individuals with type 2 diabetes.
The life expectancy of individuals with type 1 diabetes has improved significantly over the past few decades, thanks to advancements in medical care and diabetes management. However, there remains a substantial gap compared to the general population, influenced by various modifiable risk factors and the presence of chronic complications. Continued efforts in optimizing diabetes care and managing risk factors are essential to further close this gap and improve the quality of life for individuals with type 1 diabetes.
Most relevant research papers on this topic